In Moldova, hemophilia treatment can often be hours away, if available at all. So for people with hemophilia in Chisinau, Moldova, the WFH Twinning partnership with Warsaw, Poland, has provided a lot of hope.
The latest video in the Twinning series, sponsored by Wyeth, now a part of Pfizer, follows patients and participants in the Twinning partnership between the Research Institute of Mother and Child Health Care, along with the State Medical and Pharmaceutical University Testimitanu, both located in Chisinau, and the Institute of Hematology and Transfusion Medicine in Warsaw.
Iurie Dubovca is one of the many people with hemophilia whose story is told in this video, showing the need for improved hemophilia care in Moldova.
“There are lots of cases where I have an injury and I stay home and do not ask for any medical specialized help,” said Iurie Dubovca. “In two to three days the hemorrhage is gone while I stay home suffering in a lot of pain.”
“Our Twinning with Moldovia is a really worthy enterprise,” said Dr. Jerzy Windyga, head of the Department of Disorders of Hemostasis and Internal Medicine, Institute of Hematology and Transfusion Medicine in Warsaw. “Treatment has changed a lot in the past 25 years in Poland. I hope that it will also change in Moldova.”The fact that over half the people with hemophilia in Moldova attended the first Twinning Symposium held between the two countries in December 2008 demonstrates the dedication to improve care.